New Key Statistics Module, Z-Score and F-Score
NAS:ORMP Key Ratios
| Market Cap $ M | 97.56 |
| Enterprise Value $ M | -48.86 |
| P/E(ttm) | 22.00 |
| PE Ratio without NRI | 22.00 |
| Forward PE Ratio | -- |
| Price/Book | 0.62 |
| Price/Sales | 73.32 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | 13.89 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | 0.11 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.98 |
| EV-to-EBITDA | -1.97 |
| PEG | -- |
| Shares Outstanding M | 40.31 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 27.08 |
| Current Ratio | 27.08 |
| ROA % (ttm) | 2.22 |
| ROE % (ttm) | 2.75 |
| ROIC % (ttm) | -11.36 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
ORMP Number of Guru Trades
ORMP Volume of Guru Trades
Gurus Latest Trades with NAS:ORMP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ORMP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Oramed Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ORMP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers